Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

Rosa A. van Amerongen, Valesca P. Retel, Veerle M. H. Coupe, Petra M. Nederlof, Maartje J. Vogel, Wim H. van Harten

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Scopus)
Original languageEnglish
JournalECANCERMEDICALSCIENCE
Volume10
DOIs
Publication statusPublished - 28 Oct 2016

Keywords

  • NSCLC
  • Next-generation sequencing
  • budget impact
  • melanoma
  • personalised medicine
  • targeted therapy
  • test costs

Cite this